On May 10, 2018 Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, reported that it will release its financial results for the first quarter ended March 31, 2018 on Tuesday, May 15, 2018 during pre-market hours (Press release, Cancer Genetics, MAY 10, 2018, View Source [SID1234526470]). The Company will hold a conference call at 8:30 a.m. Eastern on Tuesday, May 15, 2018 to discuss the financial results and provide an update on its strategic direction and key organizational improvements being made by the Company.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CONFERENCE CALL & WEBCAST
Tuesday, May 15, 2018, 8:30 a.m. Eastern Time
Domestic: 800-289-0438
International: 323-794-2423
Conference ID: 4878415
Webcast: View Source
Replay – Available through May 29, 2018
Domestic: 844-512-2921
International: 412-317-6671
Conference ID: 4878415